This revised, expanded third edition updates the reader on this fast moving field as well providing an overall understanding of the genetics of complex diseases by using stroke as a paradigm. The reader will gain a comprehensive understanding of cerebrovascular genetics including the epidemiological evidence for the genetic basis of ischemic and hemorrhagic stroke, knowledge of its molecular basis from association, linkage and recent genome-wide studies, and also monogenic disorders. Finally, the legal and ethical complexities in dealing with these issues are discussed.Stroke Genetics is a valuable resource for neurologists, stroke physicians, hypertension specialists, internists, clinical pharmacologists and those in training, as well as researchers in the field of disease genetics. Each chapter now contains teaching/training MCQs to help with retention of information learnt from each chapter and this will be of considerable use to those training or about to the examined inthe field of inherited stroke.Additional questions via app: Download the Springer Nature Flashcards app for free and use exclusive additional material to test your knowledge.
Les mer
This revised, expanded third edition updates the reader on this fast moving field as well providing an overall understanding of the genetics of complex diseases by using stroke as a paradigm.
Introduction.- Familial stroke epidemiology.- Association study results.- GWAS.- Aneurysms/carvernous/AVM.- ICH/amyloid/microbleeds.- CADASIL.- Fabry.- MELAS.- Sickle.- Other monogenic.- White matter disease.- Carotid atherosclerosis.- Dissection.- Pharmacogenomics.- Non-Caucasian stroke genetics.- Small vessel disease.- Genetics of neuroimaging in stroke.- Cerebrovenous thrombosis.- Ethics.
Les mer
This revised, expanded third edition updates the reader on this fast moving field as well providing an overall understanding of the genetics of complex diseases by using stroke as a paradigm. The reader will gain a comprehensive understanding of cerebrovascular genetics including the epidemiological evidence for the genetic basis of ischemic and hemorrhagic stroke, knowledge of its molecular basis from association, linkage and recent genome-wide studies, and also monogenic disorders. Finally, the legal and ethical complexities in dealing with these issues are discussed.Stroke Genetics is a valuable resource for neurologists, stroke physicians, hypertension specialists, internists, clinical pharmacologists and those in training, as well as researchers in the field of disease genetics. Each chapter now contains teaching/training MCQs to help with retention of information learnt from each chapter and this will be of considerable use to those training or about to the examined in the field of inherited stroke.Additional questions via app: Download the Springer Nature Flashcards app for free and use exclusive additional material to test your knowledge.
Les mer
Includes new chapters on non-Caucasian stroke, advanced imaging and cerebral venous thrombosis Covers important & novel results from large datasets, as genetics continues to advance at an unprecedented rate Free for readers: Additional questions about the book content in the Springer Nature Flashcards app
Les mer
GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com
Les mer

Produktdetaljer

ISBN
9783031417764
Publisert
2024-04-10
Utgave
3. utgave
Utgiver
Vendor
Springer International Publishing AG
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Kombinasjonsprodukt

Om bidragsyterne

Pankaj Sharma, MD, PhD, FRCP, Reader & Consultant Neurologist, Imperial College London & Hammersmith Hospitals, London, UK. He is the Director of the Institute of Cardiovascular Research and also a consultant neurologist at Imperial College Healthcare NHS Trust. He holds a University of London Chair of Neurology at Royal Holloway. He is a former British Heart Foundation Clinician Scientist at Cambridge and a Fulbright Scholar at Harvard Medical School. He holds double doctorates from both the University of Cambridge and University of London. Most recently he led the internationally renowned Imperial College Cerebrovascular Research Unit at Imperial College London. Professor Sharma’s research seeks to use genetics, genomics and proteomics to advance human understanding of cerebrovascular disease in three key areas: prediction, diagnosis and treatment of stroke at the molecular level.  He has a particular interest in the genetics of stroke in ethnic minorities, particularlySouth Asians and Middle Eastern populations. In 2015 he was named the UK’s top Asian Doctor at the British Indian Awards. 

James F. Meschia, MD, Chair, Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA. James Meschia is chair of the Department of Neurology at Mayo Clinic Hospital in Jacksonville, Florida and his clinical interests include inherited cerebrovascular diseases, including single-gene disorders, such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Fabry disease, and sickle cell disease. He graduated from Johns Hopkins University School of Medicine, and went on to complete an internal medicine program in his home state at the University of Colorado. He then completed a neurology residency at Washington University in St. Louis, Missouri, followed by a vascular neurology fellowship at Indiana University. From there he joined Mayo Clinic staff. Dr. Meschia has authored over 200 scientific publications and has served on the editorial boards of Stroke, the European Journal of Neurology, the Journal of Stroke and Cerebrovascular Diseases, and Mayo Clinic Proceedings. He has been a member of several scientific review groups for NINDS and the American Heart Association and a fellow of the Academy of Neurology, American Neurological Association, and the American Heart Association.